These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy. Ruttala HB; Ko YT Colloids Surf B Biointerfaces; 2015 Apr; 128():419-426. PubMed ID: 25797481 [TBL] [Abstract][Full Text] [Related]
3. Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: is the crosslinked version more advantageous? Li C; Li Y; Gao Y; Wei N; Zhao X; Wang C; Li Y; Xiu X; Cui J Int J Pharm; 2014 Jul; 468(1-2):15-25. PubMed ID: 24709221 [TBL] [Abstract][Full Text] [Related]
4. PEGylated pH-Responsive Liposomes for Enhancing the Intracellular Uptake and Cytotoxicity of Paclitaxel in MCF-7 Breast Cancer Cells. Nijhawan HP; Shyamsundar P; Prabhakar B; Yadav KS AAPS PharmSciTech; 2024 Sep; 25(7):216. PubMed ID: 39289249 [TBL] [Abstract][Full Text] [Related]
5. A novel localized co-delivery system with lapatinib microparticles and paclitaxel nanoparticles in a peritumorally injectable in situ hydrogel. Hu H; Lin Z; He B; Dai W; Wang X; Wang J; Zhang X; Zhang H; Zhang Q J Control Release; 2015 Dec; 220(Pt A):189-200. PubMed ID: 26474677 [TBL] [Abstract][Full Text] [Related]
6. Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation. Yang T; Cui FD; Choi MK; Cho JW; Chung SJ; Shim CK; Kim DD Int J Pharm; 2007 Jun; 338(1-2):317-26. PubMed ID: 17368984 [TBL] [Abstract][Full Text] [Related]
7. An organic solvent-free technology for the fabrication of albumin-based paclitaxel nanoparticles for effective cancer therapy. Zhao Y; Cai C; Liu M; Zhao Y; Pei W; Chu X; Zhang H; Wang Z; Han J Colloids Surf B Biointerfaces; 2019 Nov; 183():110394. PubMed ID: 31398618 [TBL] [Abstract][Full Text] [Related]
8. Photo-responsive and NGR-mediated multifunctional nanostructured lipid carrier for tumor-specific therapy. Yang Y; Xie X; Yang Y; Zhang H; Mei X J Pharm Sci; 2015 Apr; 104(4):1328-39. PubMed ID: 25630979 [TBL] [Abstract][Full Text] [Related]
9. The enhanced longevity and liver targetability of Paclitaxel by hybrid liposomes encapsulating Paclitaxel-conjugated gold nanoparticles. Bao QY; Zhang N; Geng DD; Xue JW; Merritt M; Zhang C; Ding Y Int J Pharm; 2014 Dec; 477(1-2):408-15. PubMed ID: 25455782 [TBL] [Abstract][Full Text] [Related]
10. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo. Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391 [TBL] [Abstract][Full Text] [Related]
11. Long-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumulation of hydrophobic anticancer drug. Battogtokh G; Kang JH; Ko YT Eur J Pharm Biopharm; 2015 Oct; 96():96-105. PubMed ID: 26212785 [TBL] [Abstract][Full Text] [Related]
12. Improved Antitumor Activity of Novel Redox-Responsive Paclitaxel-Encapsulated Liposomes Based on Disulfide Phosphatidylcholine. Du Y; Wang Z; Wang T; He W; Zhou W; Li M; Yao C; Li X Mol Pharm; 2020 Jan; 17(1):262-273. PubMed ID: 31747284 [TBL] [Abstract][Full Text] [Related]
13. Paclitaxel-loaded polymeric nanoparticles based on PCL-PEG-PCL: preparation, in vitro and in vivo evaluation. Zhang L; He Y; Yu M; Song C J Control Release; 2011 Nov; 152 Suppl 1():e114-6. PubMed ID: 22195789 [No Abstract] [Full Text] [Related]
14. Paclitaxel-Loaded Macrophage Membrane Camouflaged Albumin Nanoparticles for Targeted Cancer Therapy. Cao X; Tan T; Zhu D; Yu H; Liu Y; Zhou H; Jin Y; Xia Q Int J Nanomedicine; 2020; 15():1915-1928. PubMed ID: 32256068 [TBL] [Abstract][Full Text] [Related]
15. Self-assembled PEGylated albumin nanoparticles (SPAN) as a platform for cancer chemotherapy and imaging. Lee JE; Kim MG; Jang YL; Lee MS; Kim NW; Yin Y; Lee JH; Lim SY; Park JW; Kim J; Lee DS; Kim SH; Jeong JH Drug Deliv; 2018 Nov; 25(1):1570-1578. PubMed ID: 30044159 [TBL] [Abstract][Full Text] [Related]
16. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123 [TBL] [Abstract][Full Text] [Related]
17. Paclitaxel loaded niosome nanoparticle formulation prepared via reverse phase evaporation method: an in vitro evaluation. Zarei M; Norouzian D; Honarvar B; Mohammadi M; Shamabadi HE; Akbarzadeh A Pak J Biol Sci; 2013 Mar; 16(6):295-8. PubMed ID: 24498794 [TBL] [Abstract][Full Text] [Related]
18. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer. Lv W; Cheng L; Li B Chem Pharm Bull (Tokyo); 2015; 63(2):68-74. PubMed ID: 25451039 [TBL] [Abstract][Full Text] [Related]
19. Preparation, Characterization, and Pharmacokinetic Study of a Novel Long-Acting Targeted Paclitaxel Liposome with Antitumor Activity. Han B; Yang Y; Chen J; Tang H; Sun Y; Zhang Z; Wang Z; Li Y; Li Y; Luan X; Li Q; Ren Z; Zhou X; Cong D; Liu Z; Meng Q; Sun F; Pei J Int J Nanomedicine; 2020; 15():553-571. PubMed ID: 32158208 [TBL] [Abstract][Full Text] [Related]
20. Co-delivery of epirubicin and paclitaxel using an estrone-targeted PEGylated liposomal nanoparticle for breast cancer. Tang H; Chen J; Wang L; Li Q; Yang Y; Lv Z; Bao H; Li Y; Luan X; Li Y; Ren Z; Zhou X; Cong D; Liu Z; Jia J; Chen H; Zhao W; Meng Q; Sun F; Pei J Int J Pharm; 2020 Jan; 573():118806. PubMed ID: 31678519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]